Source link : https://newshealth.biz/health-news/gene-driven-adjuvant-therapy-for-nsclc-leads-to-big-improvement-in-dfs/
(MedPage Today) — CHICAGO — Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to significantly longer disease-free survival (DFS) as compared with observation, a randomized trial showed. DFS… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115810 Author : Publish date : 2025-05-31 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-31 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8